Back
Monopar Therapeutics Stock Price Chart
10 Best Stocks to Own in 2025
Get your copy now FREE!
Sell
38
MNPR
Monopar Therapeutics
Last Price:
$31.95
Seasonality Move:
-21.29%
7 Day Trial
ALL ACCESS PASS
$
7
10 stocks to buy for the next leg of this rally
Get the full list here FREE-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.4 | Sell |
| 20-day SMA: | 37.14 | Sell |
| 50-day SMA: | 37.77 | Sell |
| 200-day SMA: | 24.61 | Buy |
| 8-day EMA: | 34.06 | Sell |
| 20-day EMA: | 36.12 | Sell |
| 50-day EMA: | 36.8 | Sell |
| 200-day EMA: | 27.35 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.59 | Sell |
| Relative Strength Index (14 RSI): | 37.28 | Sell |
| Chaikin Money Flow: | 13911 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.41 - 41.85) | Sell |
| Bollinger Bands (100): | (30.43 - 43.35) | Sell |
Monopar Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 31.73 while MNPR 8-day simple moving average is 34.40, which is a Sell signal.
-
The stock price of MNPR is 31.73 while Monopar Therapeutics 20-day SMA is 37.14, which makes it a Sell.
-
Monopar Therapeutics 50-day simple moving average is 37.77 while MNPR share price is 31.73, making it a Sell technically.
-
MNPR stock price is 31.73 and Monopar Therapeutics 200-day simple moving average is 24.61, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
38
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a SellThe current Monopar Therapeutics [MNPR] share price is $31.73. The Score for MNPR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
194M
Price in USD:
31.73
Share Volume:
17.1K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Sell
38
Monopar Therapeutics (MNPR)
is a Sell
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 31.73 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 31.73 while MNPR 8-day exponential moving average is 34.06, which is a Sell signal.
-
The stock price of MNPR is 31.73 while Monopar Therapeutics 20-day EMA is 36.12, which makes it a Sell.
-
Monopar Therapeutics 50-day exponential moving average is 36.80 while MNPR share price is 31.73, making it a Sell technically.
-
MNPR stock price is 31.73 and Monopar Therapeutics 200-day simple moving average is 27.35, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.77 per share, and an increase next year of $0.41 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -1.59, suggesting Monopar Therapeutics is a Sell
-
Monopar Therapeutics Relative Strength Index (RSI) is 37.28, which suggest Monopar Therapeutics is oversold
-
The Bollinger Bands (25) for Monopar Therapeutics is (34.41 - 41.85), which suggest Monopar Therapeutics is a Sell
-
The Bollinger Bands (100) for Monopar Therapeutics is (30.43 - 43.35), which suggest Monopar Therapeutics is a Sell
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.